| Patents for A61P 31 - Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics (179,784) |
|---|
| 12/08/2009 | US7629320 Oxyamino-pyrazolo[3,4-d]pyrimidinylribofuranose derivatives, e.g., 1-(2'-C-methyl- beta -D-ribofuranosyl)-4-methoxylamino-pyrazolo[3,4-d]pyrimidine and 1-(2'-C-methyl- beta -D-ribofuranosyl)-3-cyano-4-methoxylamino-pyrazolo[3,4-d]pyrimidine |
| 12/08/2009 | US7628990 Immunomodulatory compositions containing an immunostimulatory sequence linked to antigen and methods of use thereof |
| 12/08/2009 | US7628987 Vectors derived from antibodies for transferring substances into cells |
| 12/08/2009 | US7628983 treating edema with Kallikrein inhibitor; bovine pancreatic trypsin inhibitor mutants; possibly ecallantide |
| 12/08/2009 | CA2540858C Macrocyclic carboxylic acids and acylsulfonamides as inhibitors of hcv replication |
| 12/08/2009 | CA2485916C Non-nucleoside reverse transcriptase inhibitors |
| 12/08/2009 | CA2481994C Personal care compositions comprising a zinc containing material in an aqueous surfactant composition |
| 12/08/2009 | CA2424396C Naphthylsalicylanilides as antimicrobial and antiinflammatory agents |
| 12/08/2009 | CA2422354C Pyrazole compounds useful as protein kinase inhibitors |
| 12/08/2009 | CA2422342C Novel amide derivatives and medicinal use thereof |
| 12/08/2009 | CA2400371C Methods to prepare micelles comprising amphiphilic lipopolysaccharide compounds |
| 12/08/2009 | CA2399802C Tocopherols, tocotrienols, other chroman and side chain derivatives and uses thereof |
| 12/08/2009 | CA2375986C Substituted pyrazole compounds |
| 12/08/2009 | CA2332570C Uses of the borreliacidal epitope(s) of borrelia burgdorferi outer surface protein c (ospc) as vaccine |
| 12/08/2009 | CA2322845C Emulsion preconcentrates containing cyclosporin or a macrolide |
| 12/08/2009 | CA2314613C Azolo triazines and pyrimidines |
| 12/08/2009 | CA2302275C Solid solution beadlet |
| 12/06/2009 | CA2665955A1 Helicobacter species and cultivation thereof |
| 12/03/2009 | WO2009146347A1 Hepatitis c virus inhibitors |
| 12/03/2009 | WO2009146147A2 Target-responsive hydrogels |
| 12/03/2009 | WO2009146123A2 Compositions and methods for treating viral infections |
| 12/03/2009 | WO2009145839A1 Polyamine compounds that bind tar rna of hiv and methods of treating viral disorders |
| 12/03/2009 | WO2009145829A1 Type iii secretion inhibitors, analogs and uses thereof |
| 12/03/2009 | WO2009145690A1 Method and means for treating viral disease, in particular hiv/aids |
| 12/03/2009 | WO2009145619A1 Antibiotic composition |
| 12/03/2009 | WO2009144738A1 Medicinal applications of benzoic acid hydrazones synthesized on the basis of steroidal tigogenin |
| 12/03/2009 | WO2009144711A1 Compositions comprising red microalgae polysaccharides and metals |
| 12/03/2009 | WO2009144667A1 Monoclonal antibodies having homosubtype cross -neutralization properties against influenza a viruses subtype h1 |
| 12/03/2009 | WO2009144511A1 Treatment of ringworm |
| 12/03/2009 | WO2009144473A1 Antifungal combination therapy |
| 12/03/2009 | WO2009144365A1 Use of oligonucleotides with modified bases as antiviral agents |
| 12/03/2009 | WO2009144278A2 USES OF CONGLUTIN-γ |
| 12/03/2009 | WO2009144240A1 Composition and method for the assay and treatment of anthrax |
| 12/03/2009 | WO2009144179A1 L-menthyl-n-(2-hydroxyphenyl)carbamate |
| 12/03/2009 | WO2009144137A1 Probiotics to improve gut microbiota |
| 12/03/2009 | WO2009144037A1 Use of cell-permeable peptide inhibitors of the jnk signal transduction pathway for the treatment of various diseases |
| 12/03/2009 | WO2009143865A1 Use of cell-permeable peptide inhibitors of the jnk signal transduction pathway for the treatment of various diseases |
| 12/03/2009 | WO2009143775A1 Anti-hiv vaccines constructed based on amino acid mutation of attenuated live vaccine of eiav |
| 12/03/2009 | WO2009143609A1 Method of reducing motility in bacteria by overexpression of a gene of oi-1 genomic island |
| 12/03/2009 | WO2009143571A1 Antiviral salts |
| 12/03/2009 | WO2009129094A3 Combinations of antiviral agents and other compounds |
| 12/03/2009 | WO2009124653A3 Thienopyrimidines |
| 12/03/2009 | WO2009118296A3 Novel substituted imidazoquinolines |
| 12/03/2009 | WO2009114623A3 Angiostatic compositions comprising truncated tyrosyl-trna synthetase polypeptides and methods of using same |
| 12/03/2009 | WO2009110002A4 Novel efflux pump inhibitors |
| 12/03/2009 | WO2009102814A3 Mucosally non-irritative liquid amphotericin b formulations and methods for treating non-invasive fungus-induced mucositis |
| 12/03/2009 | WO2009100456A3 Inhibition and treatment of gastrointestinal biofilms |
| 12/03/2009 | WO2009099596A3 Macrocyclic serine protease inhibitors |
| 12/03/2009 | WO2009095503A3 Amino acid derivatives used as pharmaceutical substances |
| 12/03/2009 | WO2009091856A3 Beta-lactamase inhibitors |
| 12/03/2009 | WO2009089147A3 Methods and compositions for the treatment of cancers and pathogenic infections |
| 12/03/2009 | WO2009083520A3 Liquid oral florfenicol compositions which can be diluted in drinking water |
| 12/03/2009 | WO2009061770A3 Method of inhibiting abcg2 and related treatments |
| 12/03/2009 | WO2009043479A3 Use of eaa-mart1 (26-35) for the treatment of human cytomegalovirus infections |
| 12/03/2009 | WO2009043478A3 Use of bubuc and optionally eaa-mart1 (26-35) as a therapeutic agent for the treatment of hcmv infections |
| 12/03/2009 | WO2009038605A3 Flexible, polyvalent antiviral dendridic conjugates for the treatment of hiv/aids and enveloped viral infection |
| 12/03/2009 | WO2008093165A3 The use of pgil ohgosaccharyltransferase for o-glycosylating proteins |
| 12/03/2009 | WO2008086971A9 β-LACTAM-CONTAINING FORMULATIONS HAVING INCREASED STABILITY IN AQUEOUS SOLUTION |
| 12/03/2009 | US20090298940 All Natural Antifungal And Antimicrobial Composition And Method Thereof |
| 12/03/2009 | US20090298937 Method for Inhibiting the Growth of Bacteria |
| 12/03/2009 | US20090298911 Short interfering RNA sequences for prevention and treatment of viral infection; viricides |
| 12/03/2009 | US20090298900 Oxo-Imidazolyl Compounds |
| 12/03/2009 | US20090298874 Bacterial atp synthase binding domain |
| 12/03/2009 | US20090298873 Methods of reducing microbial resistance to drugs |
| 12/03/2009 | US20090298863 Administration of tlr7 ligands and prodrugs thereof for treatment of infection by hepatitis c virus |
| 12/03/2009 | US20090298847 Manufacturing method of solid dispersion containing itraconazole |
| 12/03/2009 | US20090298837 poly(ADP-ribose) polymerase (PARP) inhibitors such as 9-[(Hydrozinooxy)carbonyl]-2,7-dihydro-6-methoxy 3H-pyrido-[4,3,2-de]phthalazin-3-one, used for treating neuron tissue damage resulting from ischemia and reperfusion injury, depression, inflammatory bowel disorders, arthritis, gout, pain and sepsis |
| 12/03/2009 | US20090298833 Piperidinyl derivatives as modulators of chemokine receptor activity |
| 12/03/2009 | US20090298805 Topical pyrithione compositions and methods for treatment of nail fungus |
| 12/03/2009 | US20090298797 Combination therapy for the treatment of influenza |
| 12/03/2009 | US20090298786 Methods of treating viral infections with anthracycline antibiotics |
| 12/03/2009 | US20090298774 Bifunctional Molecules for Inhibiting HIV Entry |
| 12/03/2009 | US20090298751 Arylalkyl and Heteroarylalkyl Derivaties of Cyclosporine a for the Treatment and Prevention of Viral Infection |
| 12/03/2009 | US20090298750 Daptomycin for the treatment of biofilm and catheter salvage |
| 12/03/2009 | US20090298749 Dalbavancin compositions for treatment of bacterial infections |
| 12/03/2009 | US20090298748 Methods of administering dalbavancin for treatment of bacterial infections |
| 12/03/2009 | US20090298747 Methods and Compositions For Treatment of Nitric Oxide-Induced Clinical Conditions |
| 12/03/2009 | US20090298156 Thymidine Kinase Mutants and Fusion Proteins Having Thymidine Kinase and Guanylate Kinase Activities |
| 12/03/2009 | US20090298099 Gonococcal Proteins and Nucleic Acids |
| 12/03/2009 | US20090297647 Assays, method and compositions that exploit a mycobacterial iron acquistion pathway in cells |
| 12/03/2009 | US20090297641 Herbal compositions for the treatment of mucosal lesions |
| 12/03/2009 | US20090297634 Compositions for sustrained release of nitric oxide, methods of preparing same and uses thereof |
| 12/03/2009 | US20090297594 Oral Pharmaceutical Dosage Forms Comprising a Proton Pump Inhibitor and a NSAID |
| 12/03/2009 | US20090297556 Salmonella Based Oral Vaccines for Anthrax |
| 12/03/2009 | US20090297555 Recombinant human cytomegalovirus and vaccines comprising heterologous antigens |
| 12/03/2009 | US20090297549 Conserved and specific streptococcal genomes |
| 12/03/2009 | US20090297526 Membranolytic Polypeptides and Methods of Use |
| 12/03/2009 | US20090297518 Immunopotentiative composition |
| 12/03/2009 | US20090297516 Engineered lectins for viral inactivation |
| 12/03/2009 | US20090297484 Method for curing and preventing acquired immune deficiency syndrome by altering cell-surface receptors in precursor t-helper cells and mature t-helper cells to prevent human immunodeficiency virus virions access to mature helper cells |
| 12/03/2009 | US20090297482 Probiotic strain and antimicrobial peptide derived therefrom |
| 12/03/2009 | US20090297472 Hepatitis C Virus Inhibitors |
| 12/03/2009 | US20090293882 Antimicrobial compositions containing colloids of oligodynamic metals |
| 12/03/2009 | CA2726247A1 Method and means for treating viral disease, in particular hiv/aids |
| 12/03/2009 | CA2726231A1 Uses of conglutin-y |
| 12/03/2009 | CA2725627A1 Monoclonal antibodies having homosubtype cross-neutralization properties against influenza a viruses subtype h1 |
| 12/03/2009 | CA2725618A1 Antiviral salts |
| 12/03/2009 | CA2725613A1 Method of diagnosis of infection by mycobacteria and reagents therefor |
| 12/03/2009 | CA2725596A1 Method of reducing motility in bacteria by overexpression of a gene of oi-1 genomic island |
| 12/03/2009 | CA2725545A1 Use of cell-permeable peptide inhibitors of the jnk signal transduction pathway for the treatment of various diseases |